CRISPR Therapeutics AG (CRSP) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to ...

Horses with genomic edits to make them run faster have been banned from polo, but a zoo of CRISPR-edited animals is gaining ...

CRISPR stock offers bold investment potential and how strategic portfolio management can boost resilience and long-term ...

CRISPR Therapeutics (CRSP) has been making waves lately, especially after announcing promising early clinical data for its ...

In this article, we will be taking a look at the 11 Best Performing Biotech Stocks So Far in 2025. CRISPR Therapeutics AG ...

CRISPR Therapeutics AG (CRSP) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to ...

然而，随着CRISPR编辑动物物种不断增多，其所带来的伦理问题也日益引发关注。除了基因编辑马对传统观念带来冲击之外，人们还担忧基因编辑可能对动物本身及消费者的健康造成难以预料的后果。这些基因改造是否会随时间推移带来未知风险，比如，脱靶基因突变可能导致健康问题甚至过早死亡。更值得警惕的是，编辑后的基因可能遗传给后代，甚至扩散至野生种群。

Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling ...

CRISPR Therapeutics AG ( NASDAQ: CRSP) H.C. Wainwright 27th Annual Global Investment Conference September 8, 2025 4:30 PM EDT ...

A CRISPR system detects rare cancer mutations in blood with single-nucleotide precision, outperforming ddPCR through ...

Northwestern scientists have developed a new nanostructure that supercharges CRISPR’s ability to safely and efficiently enter cells, potentially unlocking its full power to treat genetic diseases. By ...